![]() |
市場調査レポート
商品コード
1646229
高気圧酸素療法の市場規模、シェア、成長分析:製品タイプ別、最終用途別、地域別 - 産業予測 2025~2032年Hyperbaric Oxygen Therapy Market Size, Share, Growth Analysis, By Product Type (Monoplace HBOT, Multiplace HBOT), By Application (Wound Healing, Decompression Sickness), By End Use, By Region - Industry Forecast 2025-2032 |
||||||
|
高気圧酸素療法の市場規模、シェア、成長分析:製品タイプ別、最終用途別、地域別 - 産業予測 2025~2032年 |
出版日: 2025年01月27日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
|
高気圧酸素療法市場規模は、2023年に362億米ドルと評価され、2024年の385億9,000万米ドルから2032年には643億5,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは6.6%で成長する見通しです。
高気圧酸素療法(HBOT)装置は、通常通常の2~3倍の高気圧下で組織に最適な酸素レベルを供給することにより、多くの病状に対処する上で極めて重要です。このプロセスにより、血流中の酸素輸送が促進され、特に放射線障害、空気塞栓症、糖尿病などの重症感染症に関連した創傷の回復において、感染症との闘いを助け、治癒を促進します。FDAは、肺塞栓症、重度の貧血、減圧症、火傷、脳膿瘍など13の医療用途でHBOTを承認しています。さらに、HBOT製品に必要な多額の投資は、現代医療におけるHBOTの治療可能性の認識の高まりを強調し、市場成長を促進すると予想されています。
Hyperbaric Oxygen Therapy Market size was valued at USD 36.2 billion in 2023 and is poised to grow from USD 38.59 billion in 2024 to USD 64.35 billion by 2032, growing at a CAGR of 6.6% during the forecast period (2025-2032).
Hyperbaric oxygen therapy (HBOT) devices are pivotal in addressing a multitude of medical conditions by delivering optimal oxygen levels to tissues under elevated atmospheric pressure, typically two to three times higher than normal. This process enhances oxygen transport in the bloodstream, aiding in the combat against infections and facilitating healing, particularly in wound recovery related to radiation damage, air embolisms, and severe infections such as diabetes. The FDA has approved HBOT for 13 medical applications, including pulmonary embolism, severe anemia, decompression sickness, burns, and brain abscesses. Furthermore, the significant investment required for HBOT products is anticipated to propel market growth, highlighting the increasing recognition of its therapeutic potential in modern medicine.
Top-down and bottom-up approaches were used to estimate and validate the size of the Hyperbaric Oxygen Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Hyperbaric Oxygen Therapy Market Segments Analysis
Global Hyperbaric Oxygen Therapy Market is segmented by Product Type, Application, End Use and region. Based on Product Type, the market is segmented into Monoplace HBOT, Multiplace HBOT and Topical HBOT devices. Based on Application, the market is segmented into Wound Healing, Decompression Sickness, Infection Treatment, Gas Embolism and Others. Based on End Use, the market is segmented into Hospitals and Clinics, Ambulatory Surgery Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Hyperbaric Oxygen Therapy Market
The growing global prevalence of diabetes is significantly driving the demand for hyperbaric oxygen therapy devices. As the number of diabetic patients continues to rise, there is an increasing need for effective treatment options that can aid in managing related complications. This trend is poised to contribute positively to the overall market growth for hyperbaric oxygen therapy over time. As healthcare professionals seek innovative solutions to improve patient outcomes, the focus on hyperbaric treatments is expected to enhance the market's upward trajectory, reflecting the critical need for advanced therapeutic devices to cater to this rising demographic.
Restraints in the Hyperbaric Oxygen Therapy Market
The high cost associated with acquiring and maintaining Hyperbaric Oxygen Therapy (HBOT) equipment poses a significant barrier to the market's growth. Additionally, the specialized knowledge and skills necessary to operate these systems are lacking in many areas, further impeding the sector's development. As healthcare providers may be hesitant to invest in such expensive technology without adequate training or understanding, these challenges could restrict the wider adoption and accessibility of HBOT. Consequently, addressing these financial and educational obstacles will be crucial for the market's potential expansion and the realization of its benefits in therapeutic settings.
Market Trends of the Hyperbaric Oxygen Therapy Market
The Hyperbaric Oxygen Therapy (HBOT) market is poised for exponential growth driven by significant technological advancements in the coming years. The rising adoption of wound healing therapies, coupled with the increased availability of monoplace HBOT systems, is creating a robust demand for these devices. Their convenience in handling and reduced reliance on hospital gas supplies further enhance their appeal. Monoplace systems not only allow for efficient management of diverse patient needs but also empower medical staff to closely monitor vital signs. Additionally, the trend towards portability and ease of use is expected to propel market expansion, making HBOT more accessible and effective.